Breaking News Instant updates and real-time market news.

ELAN

Elanco

$29.75

-0.925 (-3.02%)

, AAP

Advance Auto Parts

$142.16

-2.24 (-1.55%)

20:25
08/12/19
08/12
20:25
08/12/19
20:25

Notable companies reporting before tomorrow's open

Notable companies reporting before tomorrow's open, with earnings consensus, include Elanco Animal Health (ELAN), consensus 26c... Advance Auto Parts (AAP), consensus $2.21... IAA (IAA), consensus 39c... II-VI (IIVI), consensus 66c... Brinker (EAT), consensus $1.34.

ELAN

Elanco

$29.75

-0.925 (-3.02%)

AAP

Advance Auto Parts

$142.16

-2.24 (-1.55%)

IAA

IAA

$43.53

-1.475 (-3.28%)

IIVI

II-VI

$38.18

0.09 (0.24%)

EAT

Brinker

$39.89

-0.07 (-0.18%)

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 13

    Aug

  • 15

    Aug

  • 05

    Sep

  • 09

    Sep

  • 10

    Sep

  • 25

    Sep

  • 13

    Nov

ELAN Elanco
$29.75

-0.925 (-3.02%)

05/23/19
05/23/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Elanco (ELAN) initiated with a Neutral at Guggenheim. 2. Cooper Tire (CTB) initiated with an Overweight at KeyBanc while Goodyear Tire (GT) was initiated with a Sector Weight. 3. SciPlay (SCPL) initiated with a Buy at Craig-Hallum and an Overweight at Stephens. 4. Target Hospitality (TH) initiated with an Outperform at Credit Suisse and Oppenheimer. 5. Allogene Therapeutics (ALLO) initiated with a Hold at Stifel. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/23/19
GUGG
05/23/19
INITIATION
GUGG
Neutral
Elanco initiated with a Neutral at Guggenheim
Guggenheim analyst David Westenberg initiated coverage on 10 companies in animal health, starting Elanco with a Neutral rating. He sees limited upside potential from Credelio and Interceptor Plus and cites limited visibility into the company's pipeline, though Westenberg also expects continued strong sales of Galliprant and thinks margin expansion goals are "mostly achievable."
07/10/19
WBLR
07/10/19
NO CHANGE
WBLR
Market Perform
Elanco combination with Bayer unlikely for many reasons, says William Blair
Shares of Elanco Animal Health (ELAN) have been unusually volatility over the past two days, William Blair analyst John Kreger tells investors in a research note. On Monday, the FDA approved a generic version of the company's largest product, Rumensin, and yesterday, the media reported speculation that Bayer (BAYRY) has approached Elanco about combining their animal health businesses, the analyst explains. He believes that while a negative development, the Rumensin generic had been expected and thus does not change his modeling assumptions. The Bayer speculation is more surprising but does not seem likely to happen "for a number of reasons," says Kreger. Elanco's largest challenge is bolstering its organic revenue growth, and buying a large company that is growing at a slower pace would only add to this challenge, according the analyst. Further, Elanco has committed to deleverage its balance sheet in the coming year, he adds. And lastly, Kreger believes there could be antitrust challenges from such a large combination. He keeps a Market Perform rating on Elanco shares.
07/08/19
EVER
07/08/19
NO CHANGE
EVER
Outperform
First generic Rumensin approval earlier than Elanco expected, says Evercore ISI
Evercore ISI analyst Umer Raffat notes that the first generic for Rumensin has been approved, earlier than expected by Elanco (ELAN), which had modeled a possible generic entry in 2020. Many investors had assumed that Zoetis (ZTS) "may be the first generic" but it was "actually a Hungarian company, Huvepharma," the analyst noted. Raffat also highlighted that Rumensin is Elanco's biggest product. The analyst has an Outperform rating on Elanco's shares.
AAP Advance Auto Parts
$142.16

-2.24 (-1.55%)

07/17/19
FBCO
07/17/19
NO CHANGE
Target $195
FBCO
Outperform
Walmart partnership could serve as driver for Advance Auto Parts, says Credit Suisse
Credit Suisse analyst Seth Sigman notes that Advance Auto (AAP) has launched what appears to be the initial phases of its partnership with Walmart (WMT), adding about 5,000 SKUs to the Walmart website. The analyst ultimately believes that, if done right, this could serve as an incremental driver for Advance Auto Parts, benefiting from Walmart's growing online traffic and product offering. That said, more important for the stock in short term will be improving comps after the slow start and weather impact in Q2, along with instilling confidence in the margin outlook, he contends. Sigman has an Outperform rating and $195 price target on Advance Auto Parts' shares.
07/11/19
GSCO
07/11/19
INITIATION
Target $151
GSCO
Sell
Advance Auto Parts initiated with a Sell at Goldman Sachs
Goldman Sachs analyst Kate McShane started Advance Auto Parts with a Sell rating and $151 price target. The company continues to lag peers on a number of metrics, particularly on profitability, McShane tells investors in a research note. Her price target implies 3% share downside.
06/27/19
NRCS
06/27/19
DOWNGRADE
NRCS
Neutral
O'Reilly Automotive downgraded to Neutral from Buy at Northcoast
Northcoast analyst Seth Woolf downgraded O'Reilly Automotive (ORLY) to Neutral from Buy, stating that he is not as constructive on the space as he had been after recent channel checks that suggest demand trends slowed in May. He added that, "more importantly," his miles driven index shows total miles driven trends have "continued to stagnate" after being weak in Q1. Automotive aftermarket retailers are in an extremely competitive environment, said Woolf, who keeps Neutral ratings on O'Reilly peers AutoZone (AZO) and Advance Auto Parts (AAP).
08/12/19
JPMS
08/12/19
NO CHANGE
Target $222
JPMS
Overweight
JPMorgan likes risk/reward on Advance Auto shares into earnings
JPMorgan analyst Christopher Horvers likes the risk/reward on shares of Advance Auto Parts into the company's earnings report on August 13. The same-store-sales bar looks achievable while gross margins have upside potential as LIFO headwinds moderate, Horvers tells investors in a pre-earnings research note. He sees potential for earnings upside and believes the "easy" short case is evaporating. The analyst keeps an Overweight rating on Advance Auto with a $222 price target.
IAA IAA
$43.53

-1.475 (-3.28%)

07/02/19
GUGG
07/02/19
DOWNGRADE
Target $20
GUGG
Sell
KAR Auction downgraded to Sell after IAA spinoff at Guggenheim
As previously reported, Guggenheim analyst Ali Faghri downgraded KAR Auction (KAR) to Sell from Neutral following the company's completion of its spinoff of IAA (IAA), citing his view of the cyclical headwinds for industry wholecar volume growth, increasing online competition, slower AFC growth due to declining industry physical auction volumes and higher loan loss provisions and downside risk to guidance. He set a $20 price target on KAR shares. Separately, Faghri initiated coverage of IAA with a Buy rating and $48 price target this morning.
07/08/19
BRRR
07/08/19
INITIATION
Target $43
BRRR
Market Perform
IAA initiated with a Market Perform at Barrington
Barrington analyst Gary Prestopino started IAA (IAA) with a Market Perform rating and $43 price target. The analyst believes IAA is fairly valued at a current 20% discount to Copart (CPRT). However, as the company successfully executes on its growth and margin improvement initiatives, this discount can narrow over time to 10% or less, Prestopino tells investors in a research note.
07/31/19
07/31/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Verra Mobility (VRRM) initiated with a Neutral at Goldman Sachs. 2. Myomo (MYO) initiated with a Buy at Ascendiant. 3. Chiasma (CHMA) initiated with an Overweight at Piper Jaffray. 4. IAA (IAA) initiated with a Buy at Jefferies. 5. Veracyte (VCYT) initiated with a Buy at Lake Street. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
07/31/19
JEFF
07/31/19
INITIATION
Target $55
JEFF
Buy
IAA initiated with a Buy at Jefferies
Jefferies analyst Bret Jordan started IAA with a Buy rating and $55 price target. The company should benefit from favorable secular growth trends, including elevated vehicle utilization and increased collision frequency, leading to sustained mid-to-high single digit organic revenue growth, Jordan tells investors in a research note. He also believes opportunities exist for IAA to expand its EBITDA margin over the medium to longer term.
IIVI II-VI
$38.18

0.09 (0.24%)

05/16/19
BNCH
05/16/19
NO CHANGE
BNCH
II-VI, Lumentum may be hurt by Huawei news, says Benchmark
After the U.S. Commerce Department added Huawei Technologies and 70 affiliates to its "Entity List," which bans the Chinese company from acquiring components and technology from U.S. companies without government approval, Benchmark analyst Mark Miller noted that prior restrictions negatively impacted II-VI (IIVI), which counts Huawei among its customers. He also believes Lumentum (LITE) may be unfavorably impacted as Huawei represents about 15% of its revenue. Huawei has contributed about 13% of Micron's (MU) sales in the last two quarters and shares of Western Digital (WDC) often trade in a similar manner to Micron, added Miller. Others that he sees potentially being negatively impacted by the Huawei news include IPG Photonics (IPGP), Coherent (COHR), nLight (LASR) and Veeco (VECO).
07/09/19
BNCH
07/09/19
NO CHANGE
BNCH
Alibaba, Take-Two among Benchmark's Best Ideas for second half
Benchmark's analyst team laid out their Best Ideas for the second half of 2019, naming Alibaba (BABA), Take-Two (TTWO), BioTelemetry (BEAT), Biofrontera (BFRA), Chembio Diagnostics (CEMI), Ctrip (CTRP), Green Thumb Industries (GTBIF), II-VI (IIVI), LivePerson (LPSN), Nanometrics (NANO), Nexstar (NXST), Pegasystems (PEGA), Tabula Rasa HealthCare (TRHC) and Waitr Holdings (WTRH) to their list.
07/29/19
JPMS
07/29/19
INITIATION
Target $50
JPMS
Overweight
II-VI initiated with an Overweight at JPMorgan
JPMorgan analyst Samik Chatterjee started II-VI with an Overweight rating and $50 price target. The analyst has favorable outlook for the company's sales growth, driven by leverage to "tailwinds" in optical and wireless communication components, industrial lasers, and 3D sensing. II-VI also has a "differentiated position" in military applications and potential opportunities for "outsized" growth leveraging capabilities in silicon carbide and EUV, Chatterjee tells investors in a research note.
08/12/19
NEED
08/12/19
NO CHANGE
Target $44
NEED
Buy
II-VI price target raised to $44 from $39 at Needham
Needham analyst James Ricchiuti raised his price target on II-VI to $44 and kept his Buy rating ahead of its Q4 earnings, saying he expects a "strong quarter" amid "healthy" conditions in the optical communications market. The analyst notes that the company's China industrial business could be a source of upside despite the recent investor concerns because of its "unique" position as a key diode supplier to the local fiber laser competitors. Ricchiuti adds that II-VI's emerging platform in SiC wafers was a "growth driver" in the quarter.
EAT Brinker
$39.89

-0.07 (-0.18%)

08/07/19
OTRG
08/07/19
DOWNGRADE
OTRG
Mixed
Brinker downgraded to Mixed from Positive at OTR Global
OTR Global downgraded Brinker to Mixed from Positive. The firm's checks indicate heavy ordering from the value menu, weaker traffic and increased competition year-over-year that pressured Chili's U.S. stores during Q4, despite better momentum in off-premise sales.
07/23/19
KEYB
07/23/19
INITIATION
KEYB
Sector Weight
Brinker initiated with a Sector Weight at KeyBanc
KeyBanc analyst Eric Gonzalez started coverage of Brinker with a Sector Weight as he sees the shares near fair value. Following years of underperformance, Chili's has strung together a streak of five consecutive quarters of positive traffic growth against a category that has struggled for years to attract new user occasions, he notes. However, the analyst points out that it remains to be seen whether delivery, marketing, loyalty, and platform innovation will drive incrementality against increasingly difficult comparisons in 2020.
07/15/19
07/15/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Deere (DE) upgraded to Buy from Neutral at BofA/Merrill. 2. Brinker (EAT) upgraded to Overweight from Neutral at JPMorgan with analyst John Ivankoe saying the stock has become more attractive after the 9.5% pullback following the company's fiscal Q3 results. 3. Hilton (HLT) upgraded to Neutral from Underperform at Longbow with analyst Alton Stump citing valuation. 4. Crocs (CROX) upgraded to Overweight from Neutral at Piper Jaffray with analyst Erinn Murphy saying channel checks suggest the company's outlets have been seeing "solid" traffic during the summer season while pricing appears to be better versus the April/May season. 5. Hillenbrand (HI) upgraded to Buy from Neutral at DA Davidson with analyst Matt Summerville saying he is positive on Hillenbrand's $2B acquisition of Milacron announced last week, calling the deal "transformational" toward becoming a more diversified global enterprise and sees a "significant cash accretion potential" from the transaction. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/15/19
JPMS
07/15/19
UPGRADE
Target $43
JPMS
Overweight
Brinker upgraded to Overweight after 9.5% share pullback at JPMorgan
JPMorgan analyst John Ivankoe upgraded Brinker International to Overweight from Neutral while lowering his price target for the shares to $43 from $44. The stock has become more attractive after the 9.5% pullback following the company's fiscal Q3 results, Ivankoe tells investors in a research note. He believes the current 10.0% 2020 free cash flow yield "will get bid down." A greater free cash flow focus is likely to emerge at the August 15 analyst day that would likely materialize in lower fiscal 2020 capex and beyond, says Ivankoe.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

, FDX

FedEx

$151.94

-6.17 (-3.90%)

08:05
08/24/19
08/24
08:05
08/24/19
08:05
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMZN

Amazon.com

$1,752.00

-52 (-2.88%)

FDX

FedEx

$151.94

-6.17 (-3.90%)

UPS

UPS

$111.29

-3.91 (-3.39%)

F

Ford

$8.76

-0.27 (-2.99%)

GM

General Motors

$36.06

-1.19 (-3.19%)

DDAIF

Daimler AG

$0.00

(0.00%)

HMC

Honda

$22.90

-0.32 (-1.38%)

TM

Toyota

$127.94

-1.69 (-1.30%)

VWAGY

Volkswagen

$0.00

(0.00%)

AAPL

Apple

$202.73

-9.82 (-4.62%)

FB

Facebook

$177.69

-4.39 (-2.41%)

TWTR

Twitter

$41.01

-1.16 (-2.75%)

GOOGL

Alphabet Class A

$1,154.66

-35.75 (-3.00%)

GOOG

Alphabet

$1,151.72

-36.81 (-3.10%)

ADM

Archer Daniels

$37.44

-0.48 (-1.27%)

REGI

Renewable Energy

$11.65

0.61 (5.53%)

GPRE

Green Plains

$7.34

-0.68 (-8.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Sep

  • 15

    Sep

  • 17

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 23

    Sep

  • 24

    Sep

  • 23

    Oct

  • 23

    Oct

  • 27

    Oct

  • 13

    Nov

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

, AMD

AMD

$29.55

-2.35 (-7.37%)

04:55
08/24/19
08/24
04:55
08/24/19
04:55
Conference/Events
MUFG Securities to hold a tour »

MUFG Securities Tech Tour…

AMAT

Applied Materials

$45.12

-1.92 (-4.08%)

AMD

AMD

$29.55

-2.35 (-7.37%)

ANET

Arista Networks

$223.35

-3.84 (-1.69%)

CHKP

Check Point

$106.84

-2.36 (-2.16%)

CSCO

Cisco

$46.65

-1.55 (-3.22%)

EQIX

Equinix

$549.81

-4.27 (-0.77%)

FLEX

Flex

$9.72

-0.54 (-5.26%)

INTC

Intel

$44.97

-1.79 (-3.83%)

NVDA

Nvidia

$162.51

-8.93 (-5.21%)

OTEX

OpenText

$38.54

-0.57 (-1.46%)

PYPL

PayPal

$106.08

-2.66 (-2.45%)

RNG

RingCentral

$141.50

-0.86 (-0.60%)

SQ

Square

$61.65

-3 (-4.64%)

STX

Seagate

$46.96

-0.62 (-1.30%)

TWLO

Twilio

$127.90

-2.585 (-1.98%)

V

Visa

$175.24

-4.91 (-2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 28

    Aug

  • 29

    Aug

  • 05

    Sep

  • 06

    Sep

  • 09

    Sep

  • 10

    Sep

  • 16

    Sep

  • 17

    Sep

  • 18

    Sep

  • 19

    Sep

  • 10

    Oct

  • 15

    Oct

  • 24

    Oct

  • 27

    Oct

  • 06

    Nov

  • 13

    Nov

  • 13

    Nov

  • 12

    Dec

  • 16

    Dec

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

, COF

Capital One

$83.06

-2.68 (-3.13%)

17:57
08/23/19
08/23
17:57
08/23/19
17:57
Periodicals
Deutsche Bank, Capital One won't say if they have Trump's tax returns, NYP says »

Deutsche Bank (DB) and…

DB

Deutsche Bank

$6.98

-0.19 (-2.65%)

COF

Capital One

$83.06

-2.68 (-3.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

MXIM

Maxim Integrated

$52.14

-2.42 (-4.44%)

17:53
08/23/19
08/23
17:53
08/23/19
17:53
Hot Stocks
Maxim Integrated's Jain sells 12,683 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

GLD

SPDR Gold Shares

$144.15

2.77 (1.96%)

17:42
08/23/19
08/23
17:42
08/23/19
17:42
Hot Stocks
SPDR Gold Shares holdings rise to 859.83MT to 854.84MT »

This is the fourth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUMN

Golden Minerals

$0.27

0.0159 (6.38%)

17:33
08/23/19
08/23
17:33
08/23/19
17:33
Hot Stocks
Golden Minerals receives noncompliance notice from NYSE »

Golden Minerals announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DMPI

DelMar Pharmaceuticals

$0.77

0.0047 (0.61%)

17:25
08/23/19
08/23
17:25
08/23/19
17:25
Hot Stocks
Intracoastal Capital reports 9.99% passive stake in DelMar Pharmaceuticals »

Intracoastal Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$180.58

-6.44 (-3.44%)

17:22
08/23/19
08/23
17:22
08/23/19
17:22
Hot Stocks
Raytheon awarded $534M Army contract »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UHAL

Amerco

$339.43

-2.97 (-0.87%)

17:21
08/23/19
08/23
17:21
08/23/19
17:21
Hot Stocks
Amerco announces special cash dividend of 50c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTLA

Intellia Therapeutics

$15.77

-1.08 (-6.41%)

17:20
08/23/19
08/23
17:20
08/23/19
17:20
Syndicate
Breaking Syndicate news story on Intellia Therapeutics »

Intellia Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GD

General Dynamics

$183.42

-4.19 (-2.23%)

17:19
08/23/19
08/23
17:19
08/23/19
17:19
Hot Stocks
General Dynamics awarded $1.08B Navy contract modification »

General Dynamics has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVLN

Novelion Therapeutics

$0.66

-0.0523 (-7.37%)

17:17
08/23/19
08/23
17:17
08/23/19
17:17
Hot Stocks
Stonepine Capital reports 6.1% passive stake in Novelion Therapeutics »

Stonepine Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$376.85

-8.91 (-2.31%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Hot Stocks
Lockheed Martin awarded $2.43B Navy contract modification »

Lockheed Martin has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ONCS

OncoSec

$1.84

-0.03 (-1.60%)

17:14
08/23/19
08/23
17:14
08/23/19
17:14
Syndicate
Breaking Syndicate news story on OncoSec »

OncoSec files $50M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNXP

Tonix Pharmaceuticals

$0.42

-0.0249 (-5.60%)

17:09
08/23/19
08/23
17:09
08/23/19
17:09
Syndicate
Breaking Syndicate news story on Tonix Pharmaceuticals »

Tonix Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

17:08
08/23/19
08/23
17:08
08/23/19
17:08
General News
Trump to raises tariff rates on Chinese goods, CNBC says »

U.S. President Donald…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$284.86

-7.5 (-2.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATIS

Attis Industries

$1.03

-0.08 (-7.21%)

17:06
08/23/19
08/23
17:06
08/23/19
17:06
Hot Stocks
Attis Industries provides update on status of Nasdaq listing »

Attis Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVEO

Civeo

$1.32

-0.07 (-5.04%)

17:04
08/23/19
08/23
17:04
08/23/19
17:04
Syndicate
Breaking Syndicate news story on Civeo »

Civeo files $300M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGO

Assured Guaranty

$42.56

-1.09 (-2.50%)

16:58
08/23/19
08/23
16:58
08/23/19
16:58
Hot Stocks
Assured Guaranty CEO sells 30,300 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RMED

Ra Medical Systems

$1.87

-0.055 (-2.86%)

16:50
08/23/19
08/23
16:50
08/23/19
16:50
Hot Stocks
Ra Medical Systems discloses NYSE notice related to 10-Q filing delay »

Ra Medical Systems…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBA

Pembina Pipeline

$35.73

-0.81 (-2.22%)

16:47
08/23/19
08/23
16:47
08/23/19
16:47
Syndicate
Breaking Syndicate news story on Pembina Pipeline »

Pembina Pipeline files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

APEN

Apollo Endosurgery

$3.50

(0.00%)

16:44
08/23/19
08/23
16:44
08/23/19
16:44
Syndicate
Breaking Syndicate news story on Apollo Endosurgery »

Apollo Endosurgery files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:40
08/23/19
08/23
16:40
08/23/19
16:40
General news
Fed's Clarida said the global economy has worsened »

Fed's Clarida said…

LQDA

Liquidia Technologies

$5.23

-0.38 (-6.77%)

16:35
08/23/19
08/23
16:35
08/23/19
16:35
Syndicate
Breaking Syndicate news story on Liquidia Technologies »

Liquidia Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$175.24

-4.91 (-2.73%)

16:32
08/23/19
08/23
16:32
08/23/19
16:32
Hot Stocks
Visa CFO Prabhu sells over 25,000 class A common shares »

Visa vice chairman and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 27

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.